Status:
COMPLETED
Focal Vibrations and Neuropathic Pain in Diabetic Peripheral Neuropathy
Lead Sponsor:
Riphah International University
Conditions:
Peripheral Neuropathy
Diabetic Neuropathies
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
Most of the literature found on whole body vibrations(WBV) instead of focal muscle vibrations (FMV) in diabetic peripheral neuropathy patients. The studies found on the effects of focal vibrations cou...
Detailed Description
Diabetic neuropathy is the most common complication associated with diabetes mellitus, affecting approximately 50-70% of patients with diabetes. The prevalence of pain and of paraesthesia were 20% and...
Eligibility Criteria
Inclusion
- Diabetic type II patients.
- Score \>12 at Leeds Assessment of Neuropathic Symptoms \& Signs (LANSS)
- Diagnosis of diabetic peripheral neuropathy, using previous history, physical examination and vibration perception test of the patients
- Post diabetic duration of 10 years
- Patient with lower limb pain ranges from 3 to 5 on short form McGill pain
Exclusion
- Lower extremity amputation
- Neuropathy other than diabetes
Key Trial Info
Start Date :
April 28 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2023
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT05322746
Start Date
April 28 2022
End Date
February 28 2023
Last Update
March 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wazir Memorial Hospital
Toba Tek Singh, Punjab Province, Pakistan